JP Morgan Chase’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
22,620
+2,203
+11% +$76.6K ﹤0.01% 4591
2025
Q4
$619K Buy
20,417
+5,938
+41% +$165K ﹤0.01% 4888
2025
Q3
$278K Sell
14,479
-946
-6% -$14K ﹤0.01% 5337
2025
Q2
$173K Buy
15,425
+13,115
+568% +$137K ﹤0.01% 5308
2025
Q1
$23.7K Sell
2,310
-490
-18% -$6.11K ﹤0.01% 6104
2024
Q4
$54.3K Buy
+2,800
New +$68.3K ﹤0.01% 5986
2024
Q3
Sell
-1
Closed -$61 7758
2024
Q2
$61 Sell
1
-1
-50% -$40 ﹤0.01% 6987
2024
Q1
$32 Buy
2
+1
+100% +$20 ﹤0.01% 7109
2023
Q4
$27 Hold
1
﹤0.01% 7296
2023
Q3
$24 Buy
+1
New +$24 ﹤0.01% 7139
2022
Q2
Sell
-56
Closed -$2K 6974
2022
Q1
$2K Buy
+56
New +$1.39K ﹤0.01% 6445
2021
Q3
Sell
-11
Closed 6882
2021
Q2
$0 Buy
+11
New +$459 ﹤0.01% 6680
2020
Q1
Sell
-807
Closed -$55K 5806
2019
Q4
$55K Buy
+807
New +$51.7K ﹤0.01% 5098

Other funds holding ORKA